MedDataX Logo

Risk Factors for Aneurysm Rebleeding

NCT ID: NCT01567449

Last Updated: 2012-03-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

66 participants

Study Classification

OBSERVATIONAL

Study Start Date

2011-09-30

Study Completion Date

2012-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to examine the risk factors for aneurysm rebleeding.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

To investigate risk factors for spontaneous aneurysm rebleeding during hospitalization and to reach conclusions if any,of clinical signs for predicting rebleeding.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Subarachnoid Hemorrhage, Aneurysmal

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

the case group

The case group referred to SAH patients with aneurysm rebleeding

No interventions assigned to this group

the control group

the control group referred to SAH patients not with aneurysm rebleeding

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Individual whose clinical course was clear enough to be traced back and whose conservative treatment duration was shorter than 6 weeks was included

Exclusion Criteria

* Rebleeding patients with certain inducing factors such as:

* severe emotional episode,
* severe coughing,
* constipation,
* excessive activities, or
* with coagulation disorder,or
* with other intracranial vascular malformations,such as:

* moyamoya disease,
* arteriovenous malformation were excluded.
* Also patients who rebled while angiography were excluded.
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Fujian Medical University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Qingsong Lin

Junior Doctor of Neurosurgery,Principal Investigator,Clinical Doctor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Dezhi kang, professor

Role: STUDY_DIRECTOR

First Affiliated Hospital of Fujian Medical University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

First Affiliated Hospital,Fujian Medical University

Fuzhou, Fujian, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

qingsong lin, master

Role: CONTACT

Phone: 13489991226

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Dezhi kang, professor

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

110011

Identifier Type: -

Identifier Source: org_study_id